BALLERUP, Denmark & DUBLIN--(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to ...

Collaboration will concentrate on launching and running studies within medical dermatology Collaboration will concentrate on launching and running studies within medical dermatology LEO Pharma – a ...

DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced it has ...

BALLERUP, Denmark & DUBLIN--(BUSINESS WIRE)--#partnership--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO ...

LEO Pharma and ICON (NASDAQ:ICLR) enter a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective. This will aid LEO’s ...

Dublin, Ireland – ICON plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced it has ...

LEO Pharma, a global leader in medical dermatology, and ICON plc announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost ...